about
Histoplasmosis: a clinical and laboratory updateRecent advances in diagnosis and management of Mycotic KeratitisTherapeutic Drug Monitoring of Posaconazole: an UpdatePosaconazole: an oral triazole with an extended spectrum of activityMitochondrial Complex I Is a Global Regulator of Secondary Metabolism, Virulence and Azole Sensitivity in FungiTrypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental ModelInclusion complex of a new propiconazole derivative with β-cyclodextrin: NMR, ESI-MS and preliminary pharmacological studies.In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea sppComparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic MalignanciesEconomic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands.Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapyThe large scale antibacterial, antifungal and anti-phage efficiency of Petamcin-A: new multicomponent preparation for skin diseases treatment.Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring.In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.Discovery of a Novel Antifungal Agent in the Pathogen Box.Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options.In search of the holy grail of antifungal therapyPosaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature.Candida urinary tract infections: treatment options.Fosamprenavir calcium plus ritonavir for HIV infection.Long QT Syndrome Leading to Multiple Cardiac Arrests After Posaconazole Administration in an Immune-Compromised Patient with Sepsis: An Unusual Case ReportPosaconazole in the management of refractory invasive fungal infections.Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.New and investigational triazole agents for the treatment of invasive fungal infections.Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.Pharmacologic and clinical evaluation of posaconazole.Mucormycosis in immunochallenged patients.New generation azole antifungals in clinical investigation.Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report.Safety of triazole antifungal drugs in patients with cancer.Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.Candida tropicalis in human disease.Use of posaconazole in the treatment of invasive fungal infections.Pharmacoeconomics of voriconazole in the management of invasive fungal infections.Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence.Posaconazole: when and how? The clinician's view.
P2860
Q24675642-D3CA04C8-989D-4FDA-B9F9-C49E23D6C15CQ26744422-9E3D908C-7AEB-4FAC-AAF3-842D7E3407C0Q26746016-D67CB550-DAC8-4190-A5EF-32F2100554CFQ28291282-B0B6528D-BAEB-4B11-B576-B257AC826638Q28552733-E4AF1CDA-48E3-445E-B88A-D2FE0467A540Q28553573-D83B3764-D933-46FC-9641-BE7D8DD474ECQ30907922-62B0F8E5-2874-4B61-8607-47F740D407FDQ33525228-14E0F0C4-5811-4CBA-904B-B70274E19BBBQ33880412-2D4A4B01-0B40-4E90-8449-DEC8AF631DC4Q34013416-22C30F60-D343-4614-8687-7834F50AF076Q34754956-FD192933-C5AF-40C1-A2ED-1FAF61959567Q35624068-3F444D54-9842-4ACF-8472-1278AEE125C3Q36018743-83A6FC18-B245-43D7-8107-800478137CD8Q36094852-A2E80FF5-5A8F-4D15-A606-1CFBC1221D58Q36354735-47ED58D9-2C41-4093-A984-52D7D70C6133Q36364013-D546DE9E-CC48-4690-8569-E399E5D15F72Q36424973-C05CF6BA-8650-4F49-BBAE-0FEB87680EA7Q36491819-35502F0C-4D29-4D59-958F-EC0BF1867C4EQ36505508-70F707BF-D9EF-4E0B-8061-D799E6DD5F53Q36557963-9225CCA7-5E4E-40FA-B9C8-D19925DF299AQ36672181-5BBCCE3F-5A02-4E24-AAAB-482B5074D260Q36718486-554E38DB-3A3D-49D0-AF7C-EB782E23D28AQ36777855-26858C31-A4C2-4EA6-82D8-C614EA2A94CFQ36839698-E885CE7B-4440-49C8-9F9F-D7FF6DDC5B03Q37020761-D2B03E11-26CA-48F2-888C-8F44EC3DBACFQ37052755-63391819-5610-41FF-ABEF-783506A0C8ABQ37055215-E6DC07E4-F9DD-4572-90F3-5A9A09A9BBFFQ37364295-AE997F21-156F-43F4-A5DE-43256DFA7F19Q37404840-F61FF273-59CE-4AC7-AB2F-C77D66AB3E38Q37445943-4AF03DBE-E56C-414B-BDF7-1C8229D433EFQ37534298-4B1DEB57-A3AB-44CC-B079-2CC2E0D29BB0Q37579222-6809B970-8E30-4B4B-AC8D-E202AD63F274Q37632299-0E7F1DC7-50B6-4D9F-BAB9-366BB0A58E06Q37662650-A524C770-EF5A-4567-879D-144D4A75EFA3Q37750488-E11BCD28-9DF4-42AC-872B-04B7BCF130EEQ37794979-DC02F781-EDAA-45A9-AA40-DFC667C9073DQ37810083-EBFD19B3-E6A1-4EFE-93F6-943F19115D0CQ37820674-802B4DCF-C603-4705-9F9D-C207F138A118Q37886974-CF61D993-4EDD-43E7-9804-0CCD2C84CC4DQ37901534-A232F149-761B-4CC4-AD64-7A8ED5D6B400
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Posaconazole: a broad-spectrum triazole antifungal.
@ast
Posaconazole: a broad-spectrum triazole antifungal.
@en
type
label
Posaconazole: a broad-spectrum triazole antifungal.
@ast
Posaconazole: a broad-spectrum triazole antifungal.
@en
prefLabel
Posaconazole: a broad-spectrum triazole antifungal.
@ast
Posaconazole: a broad-spectrum triazole antifungal.
@en
P2093
P1476
Posaconazole: a broad-spectrum triazole antifungal.
@en
P2093
Dimitrios P Kontoyiannis
Harrys A Torres
Issam I Raad
Ray Y Hachem
Roy F Chemaly
P304
P356
10.1016/S1473-3099(05)70297-8
P577
2005-12-01T00:00:00Z